Olli Lohi

Medicine & Life Sciences

1. Precursor Cell Lymphoblastic Leukemia-Lymphoma 100%
2. Leukemia 77%
3. Pediatrics 68%
4. Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 40%
5. Neoplasms 30%
6. Hematopoietic Stem Cell Transplantation 29%
7. Child 28%
8. B-Lymphocytes 27%
9. human PRMT2 protein 24%
10. Young Adult 23%
11. Protein-Tyrosine Kinases 21%
12. Alveolar Rhabdomyosarcoma 21%
13. Genome 20%
14. Insulin-Like Growth Factor Binding Protein 2 20%
15. Bone Marrow Failure Disorders 19%
16. Scandinavian and Nordic Countries 19%
17. Zebrafish 18%
18. Tooth Abnormalities 17%
19. Central Nervous System Neoplasms 17%
20. Signal Transduction 17%
21. Pneumococcal Infections 17%
22. Genes 17%
23. Dentition 17%
24. Spinal Puncture 17%
25. Practice Management 17%
26. B-Cell Lymphoma 17%
27. Transcription Factors 16%
28. Hematologic Neoplasms 15%
29. Graft Rejection 15%
30. Finland 15%
31. Therapeutics 15%
32. Leukemia, Myelogenous, Chronic, BCR-ABL Positive 15%
33. Ferritins 15%
34. Registries 14%
35. Phosphoric Monoester Hydrolases 14%
36. Incidence 14%
37. Standard of Care 13%
38. Gene Fusion 13%
39. B-Cell Leukemia 13%
40. DNA Repair 13%
41. Innate Immunity 13%
42. Pharmaceutical Preparations 13%
43. Survival 13%
44. Mutation 13%
45. RNA 13%
46. Messenger RNA 12%
47. Needles 12%
48. Allografts 12%
49. Autoimmune Diseases 12%
50. Cell Lineage 12%